Transkull focal lesions in cat brain produced by ultrasound

Essential Tremor - Deep Brain Stimulation vs. Focused Ultrasound

INTRODUCTION

Essential Tremor (ET) is one of the most common tremor syndromes typically presented as action tremor, affecting mainly the upper limbs. In at least 30-50% of patients, tremor interferes with quality of life, does not respond to first-line therapies and/or intolerable adverse effects may occur. Therefore, surgery may be considered.

AREAS COVERED

In this review, the authors discuss and compare unilateral ventral intermedius nucleus deep brain stimulation (VIM DBS) and bilateral DBS with Magnetic Resonance-guided Focused Ultrasound (MRgFUS) thalamotomy, which comprises focused acoustic energy generating ablation under real-time MRI guidance. Discussion includes their impact on tremor reduction and their potential complications. Finally, the authors provide their expert opinion.

EXPERT OPINION

DBS is adjustable, potentially reversible and allows bilateral treatments; however, it is invasive requires hardware implantation, and has higher surgical risks. Instead, MRgFUS is less invasive, less expensive, and requires no hardware maintenance. Beyond these technical differences, the decision should also involve the patient, family, and caregivers.

In Vivo application and localization of transcranial focused ultrasound using dual-mode ultrasound arrays

Focused ultrasound (FUS) has been proposed for a variety of transcranial applications, including neuromodulation, tumor ablation, and blood-brain barrier opening. A flurry of activity in recent years has generated encouraging results demonstrating its feasibility in these and other applications. To date, monitoring of FUS beams has been primarily accomplished using MR guidance, where both MR thermography and elastography have been used. The recent introduction of real-time dual-mode ultrasound array (DMUA) systems offers a new paradigm in transcranial focusing. In this paper, we present first experimental results of ultrasound-guided transcranial FUS (tFUS) application in a rodent brain, both ex vivo and in vivo. DMUA imaging is used for visualization of the treatment region for placement of the focal spot within the brain. This includes the detection and localization of pulsating blood vessels at or near the target point(s). In addition, DMUA imaging is used to monitor and localize the FUS-tissue interactions in real time. In particular, a concave (40 mm radius of curvature), 32-element, 3.5-MHz DMUA prototype was used for imaging and tFUS application in ex vivo and in vivo rat models. The ex vivo experiments were used to evaluate the point spread function of the transcranial DMUA imaging at various points within the brain. In addition, DMUA-based transcranial ultrasound thermography measurements were compared with thermocouple measurements of subtherapeutic tFUS heating in rat brain ex vivo. The ex vivo setting was also used to demonstrate the capability of DMUA to produce localized thermal lesions. The in vivo experiments were designed to demonstrate the ability of the DMUA to apply, monitor, and localize subtherapeutic tFUS patterns that could be beneficial in transient blood-brain barrier opening. The results show that although the DMUA focus is degraded due to the propagation through the skull, it still produces localized heating effects within a sub-millimeter volume. In addition, DMUA transcranial echo data from brain tissue allow for reliable estimation of temperature change.

MR-guided focused ultrasound surgery, present and future

MR-guided focused ultrasound surgery (MRgFUS) is a quickly developing technology with potential applications across a spectrum of indications traditionally within the domain of radiation oncology. Especially for applications where focal treatment is the preferred technique (for example, radiosurgery), MRgFUS has the potential to be a disruptive technology that could shift traditional patterns of care. While currently cleared in the United States for the noninvasive treatment of uterine fibroids and bone metastases, a wide range of clinical trials are currently underway, and the number of publications describing advances in MRgFUS is increasing. However, for MRgFUS to make the transition from a research curiosity to a clinical standard of care, a variety of challenges, technical, financial, clinical, and practical, must be overcome. This installment of the Vision 20∕20 series examines the current status of MRgFUS, focusing on the hurdles the technology faces before it can cross over from a research technique to a standard fixture in the clinic. It then reviews current and near-term technical developments which may overcome these hurdles and allow MRgFUS to break through into clinical practice.

Comparative study of standing wave reduction methods using random modulation for transcranial ultrasonication

Various transcranial sonotherapeutic technologies have risks related to standing waves in the skull. In this study, we present a comparative study on standing waves using four different activation methods: sinusoidal (SIN), frequency modulation by noise (FMN), periodic selection of random frequency (PSRF), and random switching of both inverse carriers (RSBIC). The standing wave was produced and monitored by the schlieren method using a flat plane and a human skull. The minimum ratio RSW, which is defined by the ratio of the mean of the difference between local maximal value and local minimal value of amplitude to the average value of the amplitude, was 36% for SIN, 24% for FMN, 13% for PSRF, and 4%for RSBIC for the flat reflective plate, and it was 25% for SIN, 11% for FMN, 13% for PSRF, and 5% for RSBIC for the inner surface of the human skull. This study is expected to have a role in the development of safer therapeutic equipment.

Standing-wave suppression for transcranial ultrasound by random modulation

Low-frequency transcranial ultrasound (<<1 MHz) is being investigated for a number of brain therapies, including stroke, tumor ablation, and localized opening of the blood-brain barrier. However, lower frequencies have been associated with the production of undesired standing waves and cavitation in the brain. Presently, we examine an approach to suppress standing waves during continuous-wave (CW) transcranial application. The investigation uses a small randomization in the frequency content of the signal for suppressing standing waves. The approach is studied in an ex-vivo human skull and a plastic-walled chamber, representing idealized conditions. The approach is compared to single-frequency CW operation as well as to a swept-frequency input. Acoustic field scans demonstrate that the swept-frequency method can suppress standing waves in the plastic chamber and skull by 3.4 and 1.6 times, respectively, compared to single-frequency CW excitation. With random modulation, standing waves were reduced by 5.6 and 2 times, respectively, in the plastic chamber and skull. It is expected that the process may play a critical role in providing a safer application of the ultrasound field in the brain and may have application in other areas where standing waves may be created.

High-intensity focused ultrasound surgery of the brain: part 1--A historical perspective with modern applications

The field of magnetic resonance imaging-guided high-intensity focused ultrasound surgery (MRgFUS) is a rapidly evolving one, with many potential applications in neurosurgery. The first of 3 articles on MRgFUS, this article focuses on the historical development of the technology and its potential applications in modern neurosurgery. The evolution of MRgFUS has occurred in parallel with modern neurological surgery, and the 2 seemingly distinct disciplines share many of the same pioneering figures. Early studies on focused ultrasound treatment in the 1940s and 1950s demonstrated the ability to perform precise lesioning in the human brain, with a favorable risk-benefit profile. However, the need for a craniotomy, as well as the lack of sophisticated imaging technology, resulted in limited growth of high-intensity focused ultrasound for neurosurgery. More recently, technological advances have permitted the combination of high-intensity focused ultrasound along with magnetic resonance imaging guidance to provide an opportunity to effectively treat a variety of central nervous system disorders. Although challenges remain, high-intensity focused ultrasound-mediated neurosurgery may offer the ability to target and treat central nervous system conditions that were previously extremely difficult to address. The remaining 2 articles in this series will focus on the physical principles of modern MRgFUS as well as current and future avenues for investigation.

Clinical applications of focused ultrasound-the brain

This paper provides a historic and contemporary overview of the use of focused ultrasound for treating brain disorders.

Pre-clinical testing of a phased array ultrasound system for MRI-guided noninvasive surgery of the brain--a primate study

MRI-guided and monitored focused ultrasound thermal surgery of brain through intact skull was tested in three rhesus monkeys. The aim of this study was to determine the amount of skull heating in an animal model with a head shape similar to that of a human. The ultrasound beam was generated by a 512 channel phased array system (Exablate 3000, InSightec, Haifa, Israel) that was integrated within a 1.5-T MR-scanner. The skin was pre-cooled by degassed temperature controlled water circulating between the array surface and the skin. Skull surface temperature was measured with invasive thermocouple probes. The results showed that by applying surface cooling the skin and skull surface can be protected, and that the brain surface temperature becomes the limiting factor. The MRI thermometry was shown to be useful in detecting the tissue temperature distribution next to the bone, and it should be used to monitor the brain surface temperature. The acoustic intensity values during the 20 s sonications were adequate for thermal ablation in the human brain provided that surface cooling is used.

Therapeutic ultrasound in ischemic stroke treatment: experimental evidence

Re-opening of the occluded artery is the primary therapeutic goal in hyper-acute ischemic stroke. Systemic treatment with IV rt-PA has been shown to be beneficial at least in a 3 h 'door to needle' window and is approved within that interval in many countries. Trials of thrombolytic therapy with rt-PA demonstrated a small, but significant improvement in neurological outcome in selected patients. As recently shown, intra-arterial application of rt-PA is effective and opens the therapeutical window to 6 h, but requires invasive intra-arterial angiographic intervention in a high number of patients, who do not finally achieve thrombolysis. Ultrasound (US) is known to have several biological effects depending on the emission characteristics. At higher energy levels US alone has a thrombolytic effect. That effect is already used for clinical purposes in interventional therapy using US catheters. Recently, there is growing evidence that US at lower energy levels (<2 W/cm(2)) facilitates enzymatic mediated thrombolysis, most probably by breaking molecular linkages of fibrin polymers and therefore, increasing the working surface for the thrombolytic drug. Different in-vitro and in-vivo experiments have shown increased clot lysis as well as accelerated recanalization of occluded peripheral, coronary vessels and most recently also intracerebral arteries. Sonothrombolysis at low energy levels, however, is of great interest because of the low risk for collateral tissue damage, enabling external insonation without the need for local catheterization. Whereas little or no attenuation of US can be expected through skin and chest, intensity will be significantly attenuated if penetration of bones, particularly the skull, is required. That effect, however, is frequency dependent. Whereas >90% of intracerebral US intensity is lost (of the output power) in frequencies currently used for diagnostic purposes (mostly 2 MHz and up), that ratio is nearly reversed in the lower KHz range (<300 kHz). US at these low frequencies, however, is efficient for accelerating enzymatic thrombolysis in-vitro as well as in vivo within a wide range of intensities, from 0.5 W/cm(2) (MI approximately 0.3) to several W/cm(2). Since the emitted US beam widens with decreasing frequency, low-frequency US can insonate the entire intracerebral vasculature. That may overcome the limitation of US in the MHz range being restricted to insonation of the MCA mainstem. There are no reports in the preclinical literature about intracerebral bleeding or relevant cerebral cellular damage (either signs of necrosis or apoptosis) for US energy levels up to 1 W/cm(2). Moreover, recent investigations showed no break-down of the blood brain barrier. Safety of US exposure of the brain for therapeutic purposes has to address heating. Heating depends critically on the characteristics of the US. The most significant heating of the brain tissue itself is >1 degrees C/h using a continuous wave (CW) 2 W/cm(2) probe, whereas no significant heating could be found when using an intermittent (pulsed) emission protocol. The experimental data so far help to characterize the optimal US settings for sonothrombolysis and support the hypothesis that this combined treatment is a prospective advance in optimizing thrombolytic therapy in acute stroke.

Correlation of ultrasound phase with physical skull properties

Noninvasive treatment of brain disorders using focused ultrasound (US) requires a reliable model for predicting the distortion of the field due to the skull using physical parameters obtained in vivo. Previous studies indicate that control of US phase alone is sufficient for producing a focus through the skull using a phased US array. The present study concentrates on identifying methods to estimate phase distortion. This will be critical for the future clinical use of noninvasive brain therapy. Ten ex vivo human calvaria were examined. Each sample was imaged in water using computerized tomography (CT). The information was used to determine the inner and outer skull surfaces, thickness as a function of position, and internal structure. Phase measurement over a series of points was obtained by placing a skull fragment between a transducer and a receiver with the skull normal to the transducer. Correlation was found between the skull thickness and the US phase shift. A linear fit of the data follows that predicted by a homogeneous skull when average speed of sound 2650 m/s was used. Large variance (SD = 60 degrees, mean = 50 degrees ) indicates the additional role of internal bone speed and density fluctuations. In an attempt to reduce the variance, the skull was first studied as a three-layer structure. Next, density-dependent bone speed fluctuation was introduced to both the single-layer and three-layer models. It was determined that adjustment of the mean propagation speeds using density improves the overall phase prediction. Results demonstrate that it is possible to use thickness and density information from CT images to predict the US phase distortion induced by the skull accurately enough for therapeutic aberration correction. In addition, the measurements provide coefficients for phase dependence on skull thickness and density that can be used in clinical treatments.

Micro-receiver guided transcranial beam steering

A new method for focusing ultrasound energy in brain tissue through the skull is investigated. The procedure is designed for use with a therapeutic transducer array and a small catheter-inserted hydrophone receiver placed in the brain to guide the array's focus. When performed at high-intensity, a focal intensity on the order of several hundred watts per centimeter-squared is achieved, and cells within a target volume are destroyed. The present study tests the feasibility and range of the method using an ex vivo human skull. Acoustic phase information is obtained from the stationary receiver and used to electrically shift the beam to new locations as well as correct for aberrations due to the skull. The method is applied to a 104-element 1.1 MHz array and a 120-element 0.81 MHz array. Using these array configurations, it is determined that the method can reconstruct and steer a focus over a distance of 50 mm. Application of this minimally invasive technique for ultrasound brain therapy and surgery also is investigated in vitro with a 64-element 0.664 MHz hemisphere array designed for transskull surgery. Tissue is placed inside of a skull and a catheter-inserted receiver is inserted into the tissue. A focus intense enough to coagulate the tissue is achieved at a predetermined location 10 mm from the receiver, the maximum distance that this large element array can electronically steer the focus.